SLC5A2 and type 2 diabetes mellitus: Given that metformin, SGLT2 Is, GLP‐1 RAs and alpha‐glucosidase inhibitors may be beneficial for weight loss, while sulfonylureas, thiazolidinediones and insulin may be associated with weight gain, weight loss observed in type 2 diabetes patients nowadays are more likely to result from medication.22